R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances
Study Details
Study Description
Brief Summary
To determine the usability and technical aspects of Cordio HearO™
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The system (including App and server) will be tested under simulated use conditions with representative users to identify potential changes required to the application user interface, to improve user performance and satisfaction, and to inform future design options.
The recordings data will also be used for algorithm improvement
Study Design
Outcome Measures
Primary Outcome Measures
- Patient Usability success defined as: 1.Total and individual usability score of ≥3 in the usability questionnaire in ≥80% of the users. [2 years]
The used scale is: Usability questionnaire for the Cordio HearO™ App. This Usability questionnaire is a subjective evaluation based on Likert score of device user satisfaction. Maximum value for each item: 5 Minimum value for each item: 1 Higher scores means a better outcome
- Patient Usability success defined as: 2. Total Compliance [2 Years]
The total compliance will be determined by the total number of recording days. Success will be considered if total average compliance of 70 % of all days.
Eligibility Criteria
Criteria
Major inclusion Criteria:
-
Adults patients
-
Diagnosed with Symptomatic Chronic Heart Failure [NYHA II-IVa (ambulatory)]
-
At least one of the following:
-
One ADHF hospitalization in the last 12 months
-
One unplanned IV/SC diuretic administration in the last 6 months
-
Two unplanned IV/SC diuretic administration in the last 12 months
-
NTProBNP >500 pg/ml or BNP*> 150 pg/ml at screening visit
-
Clinically stable HF
-
Willing to participate as evidenced by signing the written informed consent.
-
Male or non-pregnant female patient (pre-menopausal women will confirm verbally).
Major exclusion Criteria:
-
Not able to read in Hebrew, Russian, Arabic, English and/or Spanish.
-
Unable to comply with daily use of the App
-
Major cardiovascular event
-
Had a Cardiac Resynchronization Device (CRT) implanted or upgrading ≤ 1 month prior to screening visit.
-
Has estimated Glomerular Filtration Rate (eGFR) < 30 ml/min/1.73 meter square (Cockroft-Gault formula).
-
Is likely to undergo heart transplantation/ LVAD within 6 months of Screening Visit.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Kurker Family Medicine | South Windsor | Connecticut | United States | 06074 |
| 2 | Lake County Med Grp | Athens | Georgia | United States | 31024 |
| 3 | Barzilai Medical Center- Cardiology | Ashkelon | Israel | ||
| 4 | Heart Failure Clinic - Clallit Be'er Sheva | Be'er Sheva | Israel | ||
| 5 | Rabin Medical Center - Cardiology- CHF | Petah tikva | Israel | 49100 |
Sponsors and Collaborators
- Cordio Medical
Investigators
- Study Director: Ronit Haviv, PhD, Cordio Medical
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CLN0016